The view inside MOA Arena from the upper box during a concert. It’s just the second quarter of the year, and SM Mall of Asia (MOA) Arena gears up for more, as it never stops hosting global scene ...
After being all-but written off a year ago, AstraZeneca’s anifrolumab has been reborn with new data that suggest it could help to end a drought in treatments for autoimmune disease systemic ...
Saphnelo (anifrolumab) is the first biologic drug for SLE to be approved in Europe that is not restricted to patients with a high degree of disease activity, according to AZ, which also notes it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback